摘要
[目的]评价在脊柱结核病灶清除植骨融合并内固定术中,应用医用硫酸钙(Osteoset)人工骨与自体骨混合植骨的安全性和临床效果。[方法]自2004年4月~2006年5月间,对24例胸腰椎结核患者行一期前路病灶消除、Osteoset人工骨加自体骨植骨并内固定术。观察患者局部伤口情况,有无不良反应及脊髓神经功能恢复情况。定期影像学检查(脊柱X线片和CT扫描),对植骨融合和后凸畸形矫正的情况进行评定和分析。[结果]所有患者术后伤口均一期愈合,未见不良全身反应。随访6~24个月,平均15个月。影像学检查显示内固定位置良好,无松动;结核病灶均无复发,脊柱后凸畸形平均矫正15.2°±6.7°,末次随访畸形矫正角度未见明显丢失。术后3个月融合率达95.8%,术后6个月24例患者植骨部位均获骨性融合。[结论]Osteoset人工骨在脊柱结核手术治疗中可以补充植骨量,具有可靠的安全性和满意的临床效果,是一种优良的骨移植替代材料。
[ Objective] To assess the safety and clinical result of Osteoset artificial bone and autogenetic bone grafting ccmbined with internal fixation after radical debridement in the treatment of spinal tuberculosis. [ Method ] From April 2004 to May 2006, 24 cases with spinal tuberculosis were treated with radical debridement, Osteoset artificial bone and autogenetic bone grafting combined with internal fixation. Radiographs (X-rays and CTs ) were analyzed to access bony fusion and deformity correction. [ Result] All the patients acquired satisfactory incision healing without fever. The follow-up period ranged from 6 to 24 months (mean 15 months ). There was no recurrence of the disease or loose instrumentation. The average Cobb's angle correction was (15.2°±6. 7°). The rate of fusion was 95. 8% 3 month after operation, while it was 100% 6 month after operation. [Condusion] Osteoset artificial bone can avoid the complications of donor bone site. The early clinical outcome is satisfying.
出处
《中国矫形外科杂志》
CAS
CSCD
北大核心
2007年第9期652-655,共4页
Orthopedic Journal of China
基金
国家自然科学基金项目(NO.30572163)